Schedule 13G ownership disclosure

PHASEBIO PHARMACEUTICALS INC

Security class unavailable · CUSIP: 717224109

Event date: 2021-10-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,925,080
Percent of class
4.0100%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902219-21-000410
Form type
SC 13G/A
Filer
PhaseBio Pharmaceuticals Inc
CIK
CIK 1169245
Filed
Nov 10, 2021
Reporting period
Oct 29, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub